Now, ”printer” that creates made-to-measure human organs

London, June 4 (ANI): Patients needing transplants would soon ask doctors to ”print” new organs for them, it has been claimed.

The California-based regenerative medicine company Organovo has already unveiled a prototype machine capable of growing new arteries.

Company bosses believe the technology could be used to create new organs.

The machine is based on 3D laser printing technology used to make new machine parts for industry.

But instead of combining layers of plastic and metal, the “bioprinter” puts together living tissue.

Two laser-based printing heads are used to place living cells onto thin sheets of gel with microscopic precision.

Thereafter, multiple layers are laid on top of each other in a specially designed “scaffold” and the cells begin to fuse together.

“Ultimately the idea would be for surgeons to have tissue on demand for various uses,” the Telegraph quoted Organovo”s chief executive Keith Murphy, as saying.

Murphy added: “The best way to do that is get a number of bio-printers into the hands of researchers and give them the ability to make three dimensional tissues on demand.” (ANI)

First 16-patient, multicenter ‘domino donor’ kidney transplant successfully completed

Washington, July 8 (ANI): Johns Hopkins experts have successfully completed the first 16-patient, multicenter “domino donor” kidney transplant.

Surgical teams at The Johns Hopkins Hospital carried out the eight-way, multihospital, domino kidney transplant in collaboration with colleagues at Barnes-Jewish Hospital in St. Louis, INTEGRIS Baptist Medical Center in Oklahoma City and Henry Ford Hospital in Detroit.

The 16 surgeries were performed on four different dates, June 15, June 16, June 22 and July 6.

They involved eight donors – 3 men and 5 women along with eight organ recipients – 3 men and 5 women.

“All Johns Hopkins patients are in good condition and are recovering as anticipated,” according to Dr. Robert A. Montgomery, the director of the Johns Hopkins Comprehensive Transplant Center.

The procedure, kidney paired donation (KPD), takes a group of incompatible donor-recipient pairs, and matches them with other pairs in a similar predicament.

By exchanging kidneys between the pairs, it is possible to give each recipient a compatible kidney.

This way, each recipient receives a kidney from a stranger, and transplants are enabled that otherwise would not have taken place.

The experts involved in the transplant say that involving multiple hospitals created even more possibilities for matches, but it also made the procedure more complex.

“We performed a similar six-way domino procedure involving three hospitals earlier this year. We managed to perform all those surgeries on the same day. However, adding two more recipients, two more donors and another hospital meant that we needed a multi-hospital team of eight anaesthesiologists, 16 nurses and nine surgeons. The logistics being that much more complicated, we decided it was best to spread the surgeries over several days, the first on June 15 and the last, July 6,” says Montgomery.

What makes the new model interesting is the fact that apart from sheer logistics, performing large numbers of transplants on one day puts a lot of strain on the doctors, nurses and staff at each hospital, and also ties up too many operating rooms.

Montgomery believes that it will serve as a blueprint for a national KPD program in which kidneys will be transported around the country, resulting in an estimated 1,500 additional transplants each year. (ANI)

Carbon monoxide can protect against arterial clotting

Washington, June 24 (ANI): Carbon monoxide might be known for its harmful effects, but a new study has shown that it can protect against arterial clotting.

Carbon monoxide is extremely poisonous, and can inhibit the exposure of oxygen, resulting in death.

However, the researchers have shown that inflamed or injured tissues up regulate heme oxygenase-1 (HO-1), a protein that both protects cells and produces CO, suggesting that low levels of CO may have protective effects.

During the study, Chen et al examined clotting mechanisms in mice that received arterial transplants.

They found that absence of HO-1 in these mice resulted in significant mortality due to arterial clotting; however, treatment with a CO-releasing molecule both decreased clotting and improved survival.

The researchers concluded that HO-1/CO plays an “important role …[in] protection against vascular arterial thrombosis in murine aortic allotransplantation.”

The study appears in the American Journal of Pathology. (ANI)

Revolutionary treatment to obtain bone marrow from stem cells on the anvil

Washington, April 17 (ANI): Researchers at Universiti de Montrial have successfully produced a large quantity of laboratory stem cells from a small number of blood stem cells obtained from bone marrow.

The research team, led by Dr. Guy Sauvageau, has taken a giant step towards the development of a revolutionary treatment based on these stem cells.

It is known that a bone marrow stem cell transplant can reconstitute the recipient’s bone marrow. The main difficulty is to obtain a sufficient number of compatible stem cells.

But these patients will be able to obtain new bone marrow within the next few years, thanks to Sauvageau and his team.

“It could be possible to envision transplants for all adults from existing umbilical cord blood banks. The stem cell content of these blood banks is currently too limited for large-scale use in adults,” Sauvageau said.

Presently, transplant recipients are condemned to take medications against rejection of the transplanted organ and suffer the side effects for the rest of their lives.

However, “mouse studies exist, showing that bone marrow stem cells can prevent the rejection typically directed against solid organs,” Sauvageau said.

Rejection occurs because the immune system cells manufactured by bone marrow attack the transplanted organ as if it were an invader.

By extrapolation from laboratory studies, it is very likely that transplanting hematopoietic stem cells collected from the organ donor and developed in the laboratory could avoid rejection of this organ.

This is why it is important to have large quantities of hematopoietic stem cells, so that compatible stem cells can be matched with the organ to be transplanted.

To produce large quantities of hematopoietic stem cells in the laboratory, the researchers identified 10 proteins out of 700 candidates.

These 10 proteins are naturally present in hematopoietic stem cells and researchers can use each of them to force these cells to multiply in the laboratory.

“The next step is to verify whether this also works in humans. Everything is already in place,” Sauvageau said.

The findings are being published in the prestigious scientific journal Cell. (ANI)

New method to reveal pancreatic stem cells unveiled

Washington, April 7 (ANI): Mario Capecchi, Nobel Laureate for Medicine in 2007, has announced the invention of a technique to reveal the stem cells camouflaged in the pancreas.

The achievement made in collaboration with Eugenio Sangiorgi, a researcher from the Catholic University of Rome, is important because, to date, scientists don’t have a method to distinguish a priori between a stem cell and any other cell in the same tissue.

“We can only infer that a cell really is a stem cell by observing its behaviour,” says Sangiorgi.

Successful life saving transplants came to take place because scientists have discovered from where they can get stem cells in some cases, but they doubted the presence of such special cells in the pancreas until some years ago.

“Together with Professor Capecchi, we had already designed in the past a novel way to mark the stem cells in a tissue: a sort of little flag, capable of helping us to effectively label the cells we were looking for,” says Sangiorgi.

For achieving this, the researchers used a molecular switch, that is a piece of DNA, which activates itself once the mouse under scrutiny takes a special drug.

When the switch was “on”, a special fluorescent protein was produced. The luminous cells were indeed the long-sought stem cells.

“In order to understand that these are really stem cells, we need only to wait. A normal cell is sooner or later destined to die. A stem cell, instead, retains its capacity to renew itself and replicate. Thus, if we can still observe, many months later, that a cell is still alive, that means it is indeed a stem cell – or a cell derived directly from the division of a stem cell,” says Sangiorgi.

Using their technique, the research team have shown that a particular subset of the pancreatic cells, the so-called acinar cells, are indeed stem cells.

These cells also produce important digestive enzymes, say the researchers.

“So far, a stem cell was really looked upon as a sort of General, in charge of all the other cells, but really doing nothing: an undifferentiated cell, but with no specific task other than generating new tissue. Acinar cells, on the other hand, despite being proved stem cells, have a well defined task in the pancreas. They are like soldiers doing their job, but also capable – when necessary – of taking over the reins of the government,” says Sangiorgi.

Capecchi and Sangiorgi believe that their work may lead to an extension of the definition of the stem cell, which will lead to a more detailed study on the proliferation mechanisms at the root of the success of these cells, and of their potential danger.

A research article on their work has been published in the Proceedings of the National Accademy of Sciences (PNAS). (ANI)

Breakthrough technique may help generate solid organs from stem cells

Washington, Mar 3 (ANI): Making a significant advance in the field of tissue engineering, scientists have developed a new technique that could help generate solid organs from stem cells in the absence of a reliable supply of blood to the interior of the developing structure.

Researchers at the Stanford University School of Medicine said that stem cells could thrive in segments of well-vascularized tissue temporarily removed from laboratory animals

And once the cells have nestled into the tissue’s nooks and crannies, it is possible to seamlessly reconnect the so-called “bioscaffold” to the animal’s circulatory system.

“Efforts to use tissue engineering to generate whole organs have largely failed primarily due to the lack of available blood vessels. Now we’ve essentially hijacked an existing structure to overcome this problem,” said Dr. Geoffrey Gurtner, associate professor of surgery.

The researchers said that they could do so by keeping the tissue adequately supplied with oxygen and nutrients while outside of the body.

The researchers speculated that the stem cells in the tissue could soon be induced to become an internal, living factory of healthy, specialized cells churning out proteins missing in people with conditions like hemophilia or diabetes.

In the long run, they hope to encourage the cells to become entire transplantable organs, such as livers or pancreases.

The technique also eliminates the chance of rejection or complications caused by the use of artificial or donor-scaffolding materials by utilizing the animal’s own tissue.

“Eventually science will find a way to fabricate an organ in all its complexity. But in the short term we need to find more options for patients who are dying while waiting for transplants,” said Gurtner.

The study features in the March issue of the FASEB Journal. (ANI)

Cotton candy may help create blood vessels

London, Feb 14 (ANI): The traditional cotton candies have been an attraction to kids for many years, and US researchers have now found a new role for the candy floss – it can help create small and intricate blood vessels.

The study led by Jason Spector of New York-Presbyterian Hospital and Leon Bellan of Cornell University has shown that cotton candies can be used as a template to grow artificial vascular networks inside engineered tissue, needed especially during transplants.

During the study, the researchers placed some candy in a non-stick mould, and poured over a polymer-resin mix that set hard after a day.

They then dissolved away the sugar using water and alcohol to leave a solid cube shot through with a network of channels.

The researchers found that the channels were similar in dimensions to real networks of capillaries, reports New Scientist magazine.

To demonstrate that blood could flow easily through the material, the researchers pumped rat blood with fluorescent labeling through the network.

The researchers are now working on creating casts using a biodegradable resin mixed with cells of a particular tissue, and coating the cast’s channels with blood vessel cells.

As the cells grow, the biodegradable resin should gradually disappear to leave an artificial tissue sample with its own blood vessel network. (ANI)

Money trail in India’s kidney ring leads to Hong Kong, Australia

Money trail in India's kidney ring leads to Hong Kong, Australia New Delhi – Indian investigative agencies have found the money trail in a multimillion-dollar kidney transplant racket leading to Hong Kong and Australia, and will ask authorities in those to help in the probe, news reports said Sunday.

The alleged kingpin of the racket, Amit Kumar, and his associates are accused of performing more than 500 kidney transplant surgeries over a decade by procuring organs for paltry sums of money from poor people and transplanting them on wealthy recipients.

The Enforcement Directorate, the agency probing the ring, has received the permission of a Delhi court to follow the trail of part of the 100 million dollars Kumar is suspected of amassing, to offshore properties and banks in Hong Kong and Australia, PTI news agency reported.

“This is a fit case where letter of rogatory is required to be issued … to the competent authorities in Hong Kong and Australia to identify the ill-gotten money earned through unlawful means and for collection of evidence,” judge AK Pathak said in a ruling Saturday.

A letter of rogatory is a formal request from a court of a country seeking assistance from authorities in other countries for collection of evidence in a criminal case.

Enforcement Directorate officials said they needed to question people in Hong Kong and Australia and collect documents as the money trail indicated Kumar had acquired assets in these two countries and had opened banks accounts in his name.

Kumar is currently in jail along with at least eight others connected with the case. He was arrested on February 7 at a forest resort in Nepal, where he had escaped to after the racket was exposed in January following complaints by impoverished labourers who said doctors in Gurgaon, a New Delhi suburb, had removed their kidneys.

Kumar has been charged under various provisions of the Indian Penal Code relating to wrongful confinement, causing hurt by dangerous weapons, cheating and criminal conspiracy.

Police suspect the transplant racket served international clients from Britain, the United States, Greece, Turkey, Lebanon, Canada, Saudi Arabia and Dubai. The clients flew into India as tourists and underwent the transplants at clinics in New Delhi and its suburbs. (dpa)